Symbols / CRBP $10.48 +1.80% Corbus Pharmaceuticals Holdings, Inc.

Healthcare • Biotechnology • United States • NCM
CRBP Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.

Fundamentals
Scroll to Statements
Market Cap 185.88M Enterprise Value 24.24M Income -78.54M Sales — Book/sh 8.38 Cash/sh 9.21
Dividend Yield — Payout 0.00% Employees 36 IPO — P/E — Forward P/E -2.15
PEG — P/S — P/B 1.25 P/C — EV/EBITDA -0.28 EV/Sales —
Quick Ratio 7.96 Current Ratio 8.07 Debt/Eq 1.11 LT Debt/Eq — EPS (ttm) -5.90 EPS next Y -4.88
EPS Growth — Revenue Growth — Earnings 2026-05-05 ROA -32.90% ROE -54.18% ROIC —
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 17.74M Shs Float 12.74M Short Float 7.92%
Short Ratio 5.36 Short Interest — 52W High 20.56 52W Low 6.10 Beta 2.79 Avg Volume 209.10K
Volume 319.68K Target Price $41.25 Recom Strong_buy Prev Close $10.29 Price $10.48 Change 1.80%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$41.25
Mean price target
2. Current target
$10.48
Latest analyst target
3. DCF / Fair value
$-38.29
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$10.48
Low
$28.00
High
$57.00
Mean
$41.25

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-10 main Oppenheimer Outperform → Outperform $57
2025-11-13 main RBC Capital Outperform → Outperform $53
2025-10-20 main Wedbush Outperform → Outperform $38
2025-10-20 reit HC Wainwright & Co. Buy → Buy $40
2025-09-17 reit HC Wainwright & Co. Buy → Buy $40
2025-08-06 main Oppenheimer Outperform → Outperform $53
2025-05-07 main RBC Capital Outperform → Outperform $58
2025-05-07 main Oppenheimer Outperform → Outperform $56
2025-05-07 main HC Wainwright & Co. Buy → Buy $40
2025-03-12 reit HC Wainwright & Co. Buy → Buy $50
2025-03-11 main Jefferies Buy → Buy $53
2025-02-28 init William Blair — → Outperform —
2025-02-18 reit HC Wainwright & Co. Buy → Buy $75
2025-02-10 reit HC Wainwright & Co. Buy → Buy $75
2024-12-02 init Piper Sandler — → Overweight $35
2024-08-07 reit RBC Capital Outperform → Outperform $82
2024-08-07 main Oppenheimer Outperform → Outperform $88
2024-08-06 reit HC Wainwright & Co. Buy → Buy $80
2024-07-10 reit Oppenheimer Outperform → Outperform $80
2024-06-26 init B. Riley Securities — → Buy $85
News
RSS: Latest CRBP news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-02 SMETHURST DOMINIC Officer — 6,097 $8.30 $50,601
2026-02-17 HODGSON IAN Chief Operating Officer — 847 $7.38 $6,253
2026-02-13 MORAN SEAN F Chief Financial Officer — 4,701 $7.78 $36,588
2026-02-13 COHEN YUVAL Chief Executive Officer — 13,871 $7.78 $107,952
2026-02-03 SMETHURST DOMINIC Officer — 3,285 $8.09 $26,575
2026-02-03 HODGSON IAN Chief Operating Officer — 2,415 $8.09 $19,537
2026-01-14 MORAN SEAN F Chief Financial Officer — 28,082 $0.00 $0
2026-01-14 COHEN YUVAL Chief Executive Officer — 50,000 $0.00 $0
2026-01-14 SMETHURST DOMINIC Officer — 28,365 $0.00 $0
2026-01-14 HODGSON IAN Chief Operating Officer — 28,365 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
85.31
+75.10%
48.72
+8.08%
45.08
+29.40%
34.84
Research And Development
70.09
+117.54%
32.22
+3.38%
31.17
+93.15%
16.14
Selling General And Administration
15.21
-7.78%
16.50
+18.61%
13.91
-25.61%
18.70
General And Administrative Expense
15.21
-7.78%
16.50
+18.61%
13.91
-25.61%
18.70
Other Gand A
15.21
-7.78%
16.50
+18.61%
13.91
-25.61%
18.70
Total Expenses
85.31
+75.10%
48.72
+8.08%
45.08
+29.40%
34.84
Operating Income
-85.31
-75.10%
-48.72
-8.08%
-45.08
-29.40%
-34.84
Total Operating Income As Reported
-85.31
-75.10%
-48.72
-8.08%
-45.08
-13.16%
-39.84
EBITDA
-78.30
-107.43%
-37.75
+5.87%
-40.10
-17.71%
-34.07
Normalized EBITDA
-78.30
-107.43%
-37.75
+5.87%
-40.10
-39.54%
-28.74
Reconciled Depreciation
0.23
-60.37%
0.59
-8.27%
0.64
-15.99%
0.76
EBIT
-78.54
-104.86%
-38.34
+5.91%
-40.75
-16.97%
-34.84
Total Unusual Items
—
—
0.01
+100.16%
-5.33
Total Unusual Items Excluding Goodwill
—
—
0.01
+100.16%
-5.33
Special Income Charges
—
—
0.00
+100.00%
-5.00
Other Special Charges
—
—
—
5.00
Net Income
-78.54
-95.32%
-40.21
+9.85%
-44.60
-5.33%
-42.35
Pretax Income
-78.54
-95.32%
-40.21
+9.85%
-44.60
-5.33%
-42.35
Net Non Operating Interest Income Expense
5.53
+24.58%
4.44
+299.77%
-2.22
-4.22%
-2.13
Interest Expense Non Operating
0.00
-100.00%
1.87
-51.48%
3.86
—
Net Interest Income
5.53
+24.58%
4.44
+299.77%
-2.22
-4.22%
-2.13
Interest Expense
0.00
-100.00%
1.87
-51.48%
3.86
—
Interest Income Non Operating
5.53
-12.38%
6.31
+285.76%
1.64
—
Interest Income
5.53
-12.38%
6.31
+285.76%
1.64
—
Other Income Expense
1.24
-69.48%
4.07
+51.08%
2.70
+150.12%
-5.38
Other Non Operating Income Expenses
1.24
-69.48%
4.07
+51.08%
2.70
+5627.65%
-0.05
Gain On Sale Of Security
—
—
0.01
+102.58%
-0.33
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-78.54
-95.32%
-40.21
+9.85%
-44.60
-5.33%
-42.35
Net Income From Continuing Operation Net Minority Interest
-78.54
-95.32%
-40.21
+9.85%
-44.60
-5.33%
-42.35
Net Income From Continuing And Discontinued Operation
-78.54
-95.32%
-40.21
+9.85%
-44.60
-5.33%
-42.35
Net Income Continuous Operations
-78.54
-95.32%
-40.21
+9.85%
-44.60
-5.33%
-42.35
Normalized Income
-78.54
-95.32%
-40.21
+9.85%
-44.60
-20.50%
-37.02
Net Income Common Stockholders
-78.54
-95.32%
-40.21
+9.85%
-44.60
-5.33%
-42.35
Diluted EPS
-5.90
-60.33%
-3.68
+64.31%
-10.31
-1.58%
-10.15
Basic EPS
-5.90
-60.33%
-3.68
+64.31%
-10.31
-1.58%
-10.15
Basic Average Shares
13.32
+22.00%
10.92
+152.23%
4.33
+3.76%
4.17
Diluted Average Shares
13.32
+22.00%
10.92
+152.23%
4.33
+3.76%
4.17
Diluted NI Availto Com Stockholders
-78.54
-95.32%
-40.21
+9.85%
-44.60
-5.33%
-42.35
Total Other Finance Cost
—
—
2.92
+37.14%
2.13
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
168.19
+7.90%
155.88
+451.35%
28.27
-57.37%
66.31
Current Assets
166.95
+9.14%
152.98
+549.69%
23.55
-60.87%
60.18
Cash Cash Equivalents And Short Term Investments
163.27
+9.53%
149.06
+613.01%
20.91
-64.68%
59.20
Cash And Cash Equivalents
28.49
+65.67%
17.20
+25.31%
13.72
-19.28%
17.00
Cash Equivalents
27.14
+123.36%
12.15
+25.33%
9.70
-26.54%
13.20
Cash Financial
1.35
-73.23%
5.05
+25.27%
4.03
+5.88%
3.81
Other Short Term Investments
134.78
+2.21%
131.86
+1736.03%
7.18
-82.98%
42.19
Receivables
—
—
—
—
Prepaid Assets
—
—
—
—
Restricted Cash
0.67
+135.09%
0.28
+48.44%
0.19
-0.25%
0.19
Other Current Assets
3.02
-16.92%
3.63
+48.24%
2.45
+209.24%
0.79
Total Non Current Assets
1.24
-57.25%
2.90
-38.57%
4.73
-22.91%
6.13
Net PPE
1.24
-50.71%
2.52
-37.61%
4.04
-26.59%
5.50
Gross PPE
5.55
-15.84%
6.59
-13.18%
7.59
-11.63%
8.59
Accumulated Depreciation
-4.31
-5.72%
-4.07
-14.54%
-3.56
-14.96%
-3.09
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
1.13
+0.62%
1.13
-5.93%
1.20
-12.95%
1.38
Other Properties
1.08
-49.27%
2.13
-30.36%
3.06
-21.14%
3.88
Leases
3.33
+0.00%
3.33
+0.00%
3.33
+0.00%
3.33
Other Non Current Assets
—
0.39
-44.20%
0.69
+9.04%
0.63
Total Liabilities Net Minority Interest
20.69
+53.83%
13.45
-61.76%
35.18
+5.57%
33.32
Current Liabilities
20.69
+75.09%
11.82
-62.95%
31.89
+152.33%
12.64
Payables And Accrued Expenses
16.20
+104.13%
7.94
-44.15%
14.21
+138.88%
5.95
Payables
2.21
-53.72%
4.79
+50.55%
3.18
+46.23%
2.17
Accounts Payable
2.21
-53.72%
4.79
+50.55%
3.18
+46.23%
2.17
Current Accrued Expenses
13.98
+343.97%
3.15
-71.44%
11.03
+192.24%
3.77
Pensionand Other Post Retirement Benefit Plans Current
2.86
+25.62%
2.28
-2.13%
2.33
+4.52%
2.22
Current Debt And Capital Lease Obligation
1.63
+1.68%
1.61
-90.90%
17.65
+298.34%
4.43
Current Debt
—
—
16.21
+414.74%
3.15
Other Current Borrowings
—
—
15.91
+469.02%
2.80
Current Capital Lease Obligation
1.63
+1.68%
1.61
+11.76%
1.44
+12.19%
1.28
Other Current Liabilities
—
—
0.04
+5.78%
0.04
Total Non Current Liabilities Net Minority Interest
0.00
-100.00%
1.63
-50.26%
3.28
-84.13%
20.68
Long Term Debt And Capital Lease Obligation
0.00
-100.00%
1.63
-49.58%
3.24
-84.32%
20.66
Long Term Debt
—
—
—
15.98
Long Term Capital Lease Obligation
0.00
-100.00%
1.63
-49.58%
3.24
-30.72%
4.68
Other Non Current Liabilities
—
—
0.04
+98.15%
0.02
Stockholders Equity
147.50
+3.56%
142.43
+2162.68%
-6.91
-120.93%
32.99
Common Stock Equity
147.50
+3.56%
142.43
+2162.68%
-6.91
-120.93%
32.99
Capital Stock
0.00
+100.00%
0.00
0.00
-100.00%
0.00
Common Stock
0.00
+100.00%
0.00
0.00
-100.00%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
17.61
+44.60%
12.18
+175.32%
4.42
+6.05%
4.17
Ordinary Shares Number
17.61
+44.60%
12.18
+175.32%
4.42
+6.05%
4.17
Additional Paid In Capital
702.98
+13.52%
619.28
+44.09%
429.78
+1.08%
425.20
Retained Earnings
-555.43
-16.47%
-476.89
-9.21%
-436.68
-11.38%
-392.08
Gains Losses Not Affecting Retained Earnings
-0.05
-251.43%
0.04
+3600.00%
-0.00
+99.21%
-0.13
Other Equity Adjustments
-0.05
-251.43%
0.04
+3600.00%
-0.00
+99.21%
-0.13
Total Equity Gross Minority Interest
147.50
+3.56%
142.43
+2162.68%
-6.91
-120.93%
32.99
Total Capitalization
147.50
+3.56%
142.43
+2162.68%
-6.91
-114.10%
48.97
Working Capital
146.26
+3.62%
141.16
+1790.92%
-8.35
-117.56%
47.54
Invested Capital
147.50
+3.56%
142.43
+1430.83%
9.30
-82.15%
52.12
Total Debt
1.63
-49.58%
3.24
-84.49%
20.89
-16.76%
25.09
Net Debt
—
—
2.48
+16.63%
2.13
Capital Lease Obligations
1.63
-49.58%
3.24
-30.73%
4.68
-21.49%
5.96
Net Tangible Assets
147.50
+3.56%
142.43
+2162.68%
-6.91
-120.93%
32.99
Tangible Book Value
147.50
+3.56%
142.43
+2162.68%
-6.91
-120.93%
32.99
Current Notes Payable
—
0.00
-100.00%
0.30
-14.81%
0.35
Interest Payable
—
0.00
-100.00%
1.34
+46.50%
0.92
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-64.49
-54.31%
-41.79
-15.77%
-36.10
+3.85%
-37.54
Cash Flow From Continuing Operating Activities
-64.49
-54.31%
-41.79
-15.77%
-36.10
+3.85%
-37.54
Net Income From Continuing Operations
-78.54
-95.32%
-40.21
+9.85%
-44.60
-5.33%
-42.35
Depreciation Amortization Depletion
0.23
-60.37%
0.59
-8.27%
0.64
-15.99%
0.76
Depreciation
0.23
-60.37%
0.59
-8.27%
0.64
-56.92%
1.49
Depreciation And Amortization
0.23
-60.37%
0.59
-8.27%
0.64
-15.99%
0.76
Other Non Cash Items
-0.23
-139.15%
0.58
-27.33%
0.81
+8.42%
0.74
Stock Based Compensation
6.29
+2.33%
6.14
+77.09%
3.47
-39.33%
5.72
Asset Impairment Charge
—
—
—
0.00
Operating Gains Losses
—
—
-0.02
-102.72%
0.75
Gain Loss On Investment Securities
—
—
0.00
-95.95%
0.08
Net Foreign Currency Exchange Gain Loss
—
—
-0.02
-103.66%
0.65
Gain Loss On Sale Of PPE
—
—
0.00
-100.00%
0.02
Change In Working Capital
9.12
+263.56%
-5.58
-236.20%
4.09
+224.11%
-3.30
Change In Receivables
—
—
—
0.00
Change In Prepaid Assets
0.63
+151.59%
-1.23
+16.39%
-1.47
-193.43%
1.57
Change In Payables And Accrued Expense
9.04
+325.57%
-4.01
-166.15%
6.06
+239.26%
-4.35
Change In Accrued Expense
11.39
+302.99%
-5.61
-211.53%
5.03
+222.88%
-4.09
Change In Payable
-2.35
-246.54%
1.60
+55.93%
1.03
+500.26%
-0.26
Change In Account Payable
-2.35
-246.54%
1.60
+55.93%
1.03
+500.26%
-0.26
Change In Other Working Capital
—
—
—
—
Change In Other Current Assets
1.05
-7.97%
1.14
+49.48%
0.76
+24.05%
0.62
Change In Other Current Liabilities
-1.61
-8.44%
-1.48
-17.63%
-1.26
-10.74%
-1.14
Investing Cash Flow
-1.64
+98.65%
-121.31
-440.36%
35.64
+18.51%
30.07
Cash Flow From Continuing Investing Activities
-1.64
+98.65%
-121.31
-440.36%
35.64
+18.51%
30.07
Net PPE Purchase And Sale
-0.01
0.00
0.00
+100.00%
-0.01
Purchase Of PPE
-0.01
0.00
0.00
+100.00%
-0.01
Sale Of PPE
—
—
0.00
-100.00%
0.01
Capital Expenditure
-0.01
—
—
-0.01
Net Investment Purchase And Sale
-1.63
+98.65%
-121.31
-440.36%
35.64
+18.49%
30.08
Purchase Of Investment
-163.09
+9.80%
-180.80
-433.58%
-33.88
+60.75%
-86.34
Sale Of Investment
161.46
+171.38%
59.49
-14.43%
69.53
-40.28%
116.42
Financing Cash Flow
77.43
-53.52%
166.58
+6004.93%
-2.82
-428.66%
-0.53
Cash Flow From Continuing Financing Activities
77.43
-53.52%
166.58
+6004.93%
-2.82
-428.66%
-0.53
Net Issuance Payments Of Debt
0.00
+100.00%
-15.48
-438.62%
-2.87
-438.59%
-0.53
Issuance Of Debt
—
0.00
-100.00%
0.37
-79.66%
1.83
Repayment Of Debt
0.00
+100.00%
-15.48
-376.75%
-3.25
-37.14%
-2.37
Long Term Debt Issuance
—
0.00
-100.00%
0.37
-73.00%
1.38
Long Term Debt Payments
0.00
+100.00%
-15.48
-376.75%
-3.25
-116.36%
-1.50
Net Long Term Debt Issuance
0.00
+100.00%
-15.48
-438.62%
-2.87
-2315.13%
-0.12
Short Term Debt Issuance
—
—
0.37
-17.45%
0.45
Short Term Debt Payments
—
—
-0.43
+50.86%
-0.87
Net Short Term Debt Issuance
—
—
-0.05
+87.30%
-0.41
Net Common Stock Issuance
77.43
-57.47%
182.06
+343405.66%
0.05
0.00
Net Other Financing Charges
—
—
-0.19
—
Changes In Cash
11.29
+225.10%
3.47
+205.95%
-3.28
+59.03%
-8.00
Beginning Cash Position
17.87
+24.14%
14.39
-18.55%
17.67
-31.17%
25.68
End Cash Position
29.16
+63.21%
17.87
+24.14%
14.39
-18.55%
17.67
Free Cash Flow
-64.50
-54.32%
-41.79
-15.77%
-36.10
+3.88%
-37.56
Interest Paid Supplemental Data
0.00
-100.00%
2.82
+8.09%
2.61
+32.36%
1.97
Amortization Of Securities
-1.37
+58.94%
-3.33
-557.51%
-0.51
-505.21%
0.12
Common Stock Issuance
77.43
-57.47%
182.06
+343405.66%
0.05
0.00
Issuance Of Capital Stock
77.43
-57.47%
182.06
+343405.66%
0.05
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category